Parallel Advisors’s Nektar Therapeutics NKTR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.2K Sell
1,053
-2
-0.2% -$52 ﹤0.01% 2030
2025
Q1
$10.8K Hold
1,055
﹤0.01% 2394
2024
Q4
$14.7K Hold
1,055
﹤0.01% 2250
2024
Q3
$20.6K Hold
1,055
﹤0.01% 2067
2024
Q2
$19.6K Hold
1,055
﹤0.01% 1980
2024
Q1
$14.8K Hold
1,055
﹤0.01% 2138
2023
Q4
$8.94K Hold
1,055
﹤0.01% 2334
2023
Q3
$9.42K Hold
1,055
﹤0.01% 2233
2023
Q2
$9.1K Hold
1,055
﹤0.01% 2207
2023
Q1
$11.1K Sell
1,055
-66
-6% -$696 ﹤0.01% 2084
2022
Q4
$38K Sell
1,121
-73
-6% -$2.47K ﹤0.01% 1399
2022
Q3
$57K Buy
1,194
+15
+1% +$716 ﹤0.01% 1203
2022
Q2
$67K Buy
1,179
+49
+4% +$2.79K ﹤0.01% 1116
2022
Q1
$94K Sell
1,130
-38
-3% -$3.16K ﹤0.01% 1010
2021
Q4
$237K Buy
1,168
+23
+2% +$4.67K 0.01% 673
2021
Q3
$308K Buy
1,145
+25
+2% +$6.73K 0.01% 556
2021
Q2
$288K Sell
1,120
-3
-0.3% -$771 0.01% 547
2021
Q1
$337K Buy
1,123
+4
+0.4% +$1.2K 0.02% 458
2020
Q4
$285K Sell
1,119
-27
-2% -$6.88K 0.02% 474
2020
Q3
$285K Buy
1,146
+82
+8% +$20.4K 0.02% 438
2020
Q2
$369K Sell
1,064
-3
-0.3% -$1.04K 0.02% 367
2020
Q1
$285K Buy
1,067
+18
+2% +$4.81K 0.02% 361
2019
Q4
$340K Buy
1,049
+5
+0.5% +$1.62K 0.03% 366
2019
Q3
$285K Hold
1,044
0.02% 380
2019
Q2
$557K Buy
1,044
+4
+0.4% +$2.13K 0.05% 217
2019
Q1
$524K Hold
1,040
0.06% 213
2018
Q4
$512K Hold
1,040
0.07% 183
2018
Q3
$951K Sell
1,040
-2
-0.2% -$1.83K 0.12% 138
2018
Q2
$763K Buy
1,042
+5
+0.5% +$3.66K 0.11% 138
2018
Q1
$1.65M Buy
+1,037
New +$1.65M 0.26% 70